Gadunan, Chin Zyrine M.

HRN: 23-51-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2023
CEFUROXIME 750MG (VIAL)
08/06/2023
08/13/2023
IVT
600mg
Q8
Sti Sec To Va, Laceratd Wound Face Sec To Va
Waiting Final Action 
08/07/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
08/07/2023
08/14/2023
TOPICAL
0.5%
BID
Lacerated Wound Sec To VA
Waiting Final Action 
08/07/2023
MUPIROCIN 2%, 15G (TUBE)
08/07/2023
08/14/2023
TOPICAL
2%
BID
Lacerated Wound Sec To VA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: